Oxypertine

Oxypertine
Clinical data
Trade names	Oxypertine, others
Other names	WIN-18501; WIN18501; WIN-18,501, Win-18501; Win-18501-2
AHFS/Drugs.com	International Drug Names
Routes of; administration	By mouth
ATC code	N05AE01 (WHO) ;
Legal status
Legal status	BR: Class C1 (Other controlled substances); In general: ℞ (Prescription only);
Identifiers
	IUPAC name 5,6-Dimethoxy-2-methyl-3-[2-(4-phenylpiperazin-1-yl)ethyl]-1H-indole;
CAS Number	153-87-7 ;
PubChem CID	4640;
ChemSpider	4479 ;
UNII	5JGL4G25R7;
KEGG	D01219 ;
CompTox Dashboard (EPA)	DTXSID20165185 ;
ECHA InfoCard	100.005.291
Chemical and physical data
Formula	C23H29N3O2
Molar mass	379.504 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=C(C2=CC(=C(C=C2N1)OC)OC)CCN3CCN(CC3)C4=CC=CC=C4;
	InChI InChI=1S/C23H29N3O2/c1-17-19(20-15-22(27-2)23(28-3)16-21(20)24-17)9-10-25-11-13-26(14-12-25)18-7-5-4-6-8-18/h4-8,15-16,24H,9-14H2,1-3H3 ; Key:XCWPUUGSGHNIDZ-UHFFFAOYSA-N ;
	(verify)

Oxypertine, sold under the brand name Oxypertine among others, is an antipsychotic medication of the tryptamine and phenylpiperazine groups which was previously used in the treatment of schizophrenia but is no longer marketed. It was also evaluated for the treatment of anxiety.